PL1986669T3 - Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia - Google Patents

Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia

Info

Publication number
PL1986669T3
PL1986669T3 PL07704583T PL07704583T PL1986669T3 PL 1986669 T3 PL1986669 T3 PL 1986669T3 PL 07704583 T PL07704583 T PL 07704583T PL 07704583 T PL07704583 T PL 07704583T PL 1986669 T3 PL1986669 T3 PL 1986669T3
Authority
PL
Poland
Prior art keywords
bifidobacterium longum
inflammation
prevention
treatment
baaa
Prior art date
Application number
PL07704583T
Other languages
English (en)
Inventor
Annick Mercenier
Stéphanie Blum-Sperisen
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL1986669T3 publication Critical patent/PL1986669T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL07704583T 2006-02-15 2007-02-14 Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia PL1986669T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06101690 2006-02-15
EP07704583A EP1986669B1 (en) 2006-02-15 2007-02-14 Use of bifidobacterium longum for the prevention and treatment of inflammation
PCT/EP2007/051448 WO2007093619A1 (en) 2006-02-15 2007-02-14 Use of bifidobacterium longum for the prevention and treatment of inflammation

Publications (1)

Publication Number Publication Date
PL1986669T3 true PL1986669T3 (pl) 2012-09-28

Family

ID=36636972

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07704583T PL1986669T3 (pl) 2006-02-15 2007-02-14 Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia

Country Status (16)

Country Link
US (2) US8916145B2 (pl)
EP (1) EP1986669B1 (pl)
CN (1) CN101420965B (pl)
AT (1) ATE551063T1 (pl)
AU (1) AU2007216461B2 (pl)
BR (1) BRPI0707937A2 (pl)
CA (1) CA2642431A1 (pl)
ES (1) ES2381211T3 (pl)
MX (1) MX2008010422A (pl)
MY (1) MY148872A (pl)
PH (1) PH12012500739A1 (pl)
PL (1) PL1986669T3 (pl)
PT (1) PT1986669E (pl)
RU (1) RU2445362C2 (pl)
WO (1) WO2007093619A1 (pl)
ZA (1) ZA200807879B (pl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP2110028A1 (en) 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2318513B1 (en) * 2008-07-11 2012-09-19 Chr. Hansen A/S New probiotic bifidobacterium longum
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
US9034314B2 (en) * 2008-11-03 2015-05-19 Nestec S.A. Nutritional composition comprising probiotics and improving sleep patterns
AU2009315298A1 (en) * 2008-11-11 2010-05-20 Alimentary Health Limited Bifidobacterium longum
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
MY163002A (en) 2009-08-18 2017-07-31 Nestec Sa A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
RU2557310C2 (ru) * 2009-11-11 2015-07-20 Алиментари Хелс Лимитед ШТАММ Bifidobacterium longum, ПРИГОДНЫЙ ДЛЯ ПРИМЕНЕНИЯ В ИММУНОМОДУЛЯЦИИ, ИНДУКЦИИ ПРОДУКЦИИ ЦИТОКИНОВ, ЛЕЧЕНИИ АУТОИММУННОГО ЗАБОЛЕВАНИЯ, КОНТРОЛЕ ОТНОШЕНИЯ IL - 10:IL - 12, И ЕГО ИСПОЛЬЗОВАНИЕ
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
EP3533908B1 (en) 2010-07-02 2026-07-01 The Procter & Gamble Company NONWOVEN FABRIC COMPRISING ONE OR MORE ACTIVE AGENTS
JP5859526B2 (ja) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー 活性剤不織布ウェブを含むフィラメント及びその製造方法
MX382405B (es) 2010-07-02 2025-03-13 Procter & Gamble Método para suministrar un agente activo.
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
PT2734049T (pt) 2011-06-20 2018-07-24 Heinz Co Brands H J Llc Composições e métodos probióticos
MX390997B (es) * 2011-10-18 2025-03-21 Soc Des Produits Nestle S A Star Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal.
CN103820357A (zh) * 2013-12-30 2014-05-28 上海交大昂立股份有限公司 一株长双歧杆菌及其防治食物过敏的功能
CN105816484A (zh) * 2015-01-07 2016-08-03 东宇生物科技股份有限公司 用于腹膜透析病患预防腹膜炎并减少肾功能恶化的组合物
CN108367033A (zh) * 2015-08-31 2018-08-03 雀巢产品技术援助有限公司 使用长双歧杆菌治疗或预防抑郁症状的方法和组合物
US20180369297A1 (en) * 2015-12-14 2018-12-27 Metabogen Ab Treatment of intrahepatic cholestasis and related liver diseases
CN110191700A (zh) 2017-01-27 2019-08-30 宝洁公司 可溶性固体结构形式的组合物
CN110167639B (zh) 2017-01-27 2022-10-14 宝洁公司 呈包含泡腾型附聚颗粒的可溶性固体结构形式的组合物
SG11201907043VA (en) * 2017-01-31 2019-08-27 Univ Industry Cooperation Group Kyung Hee Univ Novel lactic acid bacteria and use thereof
JP6923673B2 (ja) 2017-05-16 2021-08-25 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 溶解性固形構造体の形態のコンディショニングヘアケア組成物
JP7273824B2 (ja) * 2017-12-29 2023-05-15 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
MX2021003224A (es) * 2018-10-02 2021-05-27 Nestle Sa Combinacion de probioticos para el tratamiento de trastornos gastrointestinales relacionados con la inflamacion.
CN113660941A (zh) * 2018-12-21 2021-11-16 雀巢产品有限公司 用于治疗变态反应性疾病的益生菌组合
JP7381613B2 (ja) 2019-06-28 2023-11-15 ザ プロクター アンド ギャンブル カンパニー アニオン性界面活性剤を含有する溶解性固体繊維性物品
CN114402062B (zh) * 2019-07-01 2025-02-25 雀巢产品有限公司 产生丝氨酸蛋白酶抑制剂
CN114555635B (zh) 2019-07-01 2024-12-17 雀巢产品有限公司 产生丝氨酸蛋白酶抑制剂
WO2022027067A1 (en) 2020-07-31 2022-02-03 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
KR102343938B1 (ko) * 2020-09-02 2021-12-28 주식회사 비피도 재조합 비피도박테리움 비피덤 bgn4를 포함하는 염증 개선용 조성물
CN112159784A (zh) * 2020-10-29 2021-01-01 佛山市朗芯生物科技有限公司 长双歧杆菌nx-4及其在制备治疗和/或预防过敏性疾病药物中的应用
CH718355A2 (fr) * 2021-02-16 2022-08-31 Nestle Sa Composition et kit pour soulager les symptômes de l'allergie respiratoire.
EP4395730A1 (en) 2021-08-30 2024-07-10 The Procter & Gamble Company Dissolvable solid structure comprising first and second polymeric structurants
US12576013B2 (en) 2021-12-17 2026-03-17 The Procter & Gamble Company Dissolvable solid fibrous shampoo articles containing salts
CN114574390B (zh) * 2022-03-09 2024-03-01 江南大学 一株缓解结肠炎的长双歧杆菌婴儿亚种及应用
US12540238B2 (en) 2022-03-10 2026-02-03 The Procter & Gamble Company Dissolvable solid structure having first and second layers
WO2026117106A1 (ko) * 2024-11-29 2026-06-04 주식회사 바이오뱅크힐링 비피도박테리움 롱검 균주 또는 락티카제이바실러스 람노서스 균주, 그의 유래 소포체 및 그의 항염증 및 항균 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
ES2124060T5 (es) 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
DE29724815U1 (de) 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
RU2210592C1 (ru) * 2001-12-27 2003-08-20 Российский государственный медицинский университет ШТАММ БАКТЕРИЙ Bifidobacterium longum 58B ДЛЯ ПРИГОТОВЛЕНИЯ БИОЛОГИЧЕСКИ АКТИВНЫХ ДОБАВОК, РЕГУЛИРУЮЩИХ МИКРОФЛОРУ КИШЕЧНИКА У ДЕТЕЙ РАННЕГО ВОЗРАСТА
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
AU2004233658B2 (en) * 2003-03-13 2009-10-29 Kirin Holdings Kabushiki Kaisha Antiallergic composition
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula

Also Published As

Publication number Publication date
RU2445362C2 (ru) 2012-03-20
AU2007216461A1 (en) 2007-08-23
RU2008136876A (ru) 2010-03-20
EP1986669B1 (en) 2012-03-28
MX2008010422A (es) 2008-10-27
CN101420965A (zh) 2009-04-29
PH12012500739A1 (en) 2013-06-17
EP1986669A1 (en) 2008-11-05
AU2007216461B2 (en) 2012-08-30
CN101420965B (zh) 2013-08-07
CA2642431A1 (en) 2007-08-23
MY148872A (en) 2013-06-14
US8916145B2 (en) 2014-12-23
US20120201785A1 (en) 2012-08-09
WO2007093619A1 (en) 2007-08-23
PT1986669E (pt) 2012-05-15
US9456630B2 (en) 2016-10-04
ES2381211T3 (es) 2012-05-24
US20090274661A1 (en) 2009-11-05
ATE551063T1 (de) 2012-04-15
ZA200807879B (en) 2009-12-30
BRPI0707937A2 (pt) 2011-05-10

Similar Documents

Publication Publication Date Title
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
AU2008232453A8 (en) Methods and compositions for reduction of side effects of therapeutic treatments
EA201491358A1 (ru) Вводимые перорально кортикостероидные композиции
GB2467670A (en) Chemical entities and therapeutic uses thereof
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
IL201479A (en) Use of tapentadol for the preparation of pain medication
MX2011007589A (es) Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20.
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
CL2012001080A1 (es) Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida.
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
PL2197287T3 (pl) Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego
CL2008003201A1 (es) Composicion farmaceutica que comprende 0,5 a 50 mg de gaboxadol o una sal farmaceuticamente aceptable de este, y uno o mas inhibidores de pat1 y/o uno o mas inhibidores de oat, en donde dicha composicion brinda un perfil plasmatico in vivo con un tmax superior a 20 minutos, util en tratamientos de trastornos del sueno.
WO2009068708A8 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MY158310A (en) Prevention and treatment of allergic diarrhoea
SG169346A1 (en) Use of yeast flakes for treating and/or preventing hyperinsulinemia
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
IL194353A0 (en) Lysobactin amides
WO2009019307A3 (en) Oral calcitonin compositions and applications thereof
EA200801890A1 (ru) Средство для лечения шума в ушах